中国临床实用医学
中國臨床實用醫學
중국림상실용의학
CHINA CLINICAL PRACTICAL MEDICINE
2009年
12期
66-68
,共3页
高传江%杨海云%罗葆明%李红%赵冬平
高傳江%楊海雲%囉葆明%李紅%趙鼕平
고전강%양해운%라보명%리홍%조동평
超声造影(CEUS)%再次或多次冷循环射频消融(repeatedCRFA)%残留病灶%原发性肝癌(HCC)
超聲造影(CEUS)%再次或多次冷循環射頻消融(repeatedCRFA)%殘留病竈%原髮性肝癌(HCC)
초성조영(CEUS)%재차혹다차랭순배사빈소융(repeatedCRFA)%잔류병조%원발성간암(HCC)
Contrast-enhanced ultrasound(CEUS)%Repeated cooled radio frequency ablation(repeated CRFA)%Residual lesion%HCC
目的 通过对原发性肝癌(HCC)患者病灶再次及多次进行冷循环射频消融(CRFA)前后超声造影(CEUS)的观察,探讨超声造影方法 评估治疗疗效.方法 58例HCC患者均已经接受CRFA治疗1次,在第一次CRFA结束后10 min、每隔2周~1月经增强CT(CECT)或CEUS证实局部有残留病灶;在CEUS的监测下,再次或多次进行射频消融治疗.结果 58位HCC患者共进行CRFA治疗245次(第一次治疗共58次),平均(3±1.78)次;第一组:病灶直径<3 cm,11例共18个病灶;第二组:病灶直径3~5 cm;42例共53个病灶;第三组:病灶直径>5 cm,最大直径10.2 cm,5例共9个病灶;第一组全部再次或多次进行了CRFA治疗;而第二、三组则是进行了CRFA+TACE或PEIT联合治疗;随着时间的推移,肝脏出现多发病灶、门静脉癌栓的几率增加,且与原癌灶的直径有相关性,P<0.05.第一组与后两组的1、2、3年生存率存在着差异,P<0.001.结论 CEUS可以动态显示靶区的微循环特点、残存病灶的形态及门静脉癌栓的形态特点,在选择治疗方式方面具有重要的指导意义.
目的 通過對原髮性肝癌(HCC)患者病竈再次及多次進行冷循環射頻消融(CRFA)前後超聲造影(CEUS)的觀察,探討超聲造影方法 評估治療療效.方法 58例HCC患者均已經接受CRFA治療1次,在第一次CRFA結束後10 min、每隔2週~1月經增彊CT(CECT)或CEUS證實跼部有殘留病竈;在CEUS的鑑測下,再次或多次進行射頻消融治療.結果 58位HCC患者共進行CRFA治療245次(第一次治療共58次),平均(3±1.78)次;第一組:病竈直徑<3 cm,11例共18箇病竈;第二組:病竈直徑3~5 cm;42例共53箇病竈;第三組:病竈直徑>5 cm,最大直徑10.2 cm,5例共9箇病竈;第一組全部再次或多次進行瞭CRFA治療;而第二、三組則是進行瞭CRFA+TACE或PEIT聯閤治療;隨著時間的推移,肝髒齣現多髮病竈、門靜脈癌栓的幾率增加,且與原癌竈的直徑有相關性,P<0.05.第一組與後兩組的1、2、3年生存率存在著差異,P<0.001.結論 CEUS可以動態顯示靶區的微循環特點、殘存病竈的形態及門靜脈癌栓的形態特點,在選擇治療方式方麵具有重要的指導意義.
목적 통과대원발성간암(HCC)환자병조재차급다차진행랭순배사빈소융(CRFA)전후초성조영(CEUS)적관찰,탐토초성조영방법 평고치료료효.방법 58례HCC환자균이경접수CRFA치료1차,재제일차CRFA결속후10 min、매격2주~1월경증강CT(CECT)혹CEUS증실국부유잔류병조;재CEUS적감측하,재차혹다차진행사빈소융치료.결과 58위HCC환자공진행CRFA치료245차(제일차치료공58차),평균(3±1.78)차;제일조:병조직경<3 cm,11례공18개병조;제이조:병조직경3~5 cm;42례공53개병조;제삼조:병조직경>5 cm,최대직경10.2 cm,5례공9개병조;제일조전부재차혹다차진행료CRFA치료;이제이、삼조칙시진행료CRFA+TACE혹PEIT연합치료;수착시간적추이,간장출현다발병조、문정맥암전적궤솔증가,차여원암조적직경유상관성,P<0.05.제일조여후량조적1、2、3년생존솔존재착차이,P<0.001.결론 CEUS가이동태현시파구적미순배특점、잔존병조적형태급문정맥암전적형태특점,재선택치료방식방면구유중요적지도의의.
Objective To evaluate the efficacy of CEUS(contrast enhanced ultrasonography)in accessing the repeated curative effects of cooled radiofrequency therapy for hepacellular carcinoma(HCC).Methods 58 cases of residual lesion of HCC which had been treated with CRFA once received repeated CRFA treatment by the guidence of CEUS 10 minutes,every 2 weeks to 1 month after first CRFA.All these patients recruited for CECT and CEUS and residual lesions were verified.Results 58 cases received 245 CRFA treatment.mean of repeated CRFA(3±1.78)times.In group 1,there were 11 eases with 18 lesions,the diameter of lesion <3 cm.In group 2,42 cases with 53 lesions which the diameter were between 3 cm to 5 cm.In group 3,5 cases with 9 lesions of which the biggest diameter was 10.2 cm.all of the lesions's diameter were>5 cm.The cases of group 1 were treated with CRFA only,while the other groups were treated with combined therapies,ie:CRFA +TACE or PEIT.The appearance of multiple lesions and portal venous carcinomous emblia increased as time went by which correlated with the size of primary lesions,P<0.05.The 1,2,3 year-survival rates of group 1 differed significant from the other two groups,P<0.001.Conclusion CEUS Can dynamically show the characteristics of microcirculation,the contours of residual lesions,the portal venous emblia which can play an important role in selecting modalities of therapy to treat.